Therefore, it is not likely that the impaired induction of anti-tumor CD8+ T cells observed in Batf3−/− mice in our study is caused by T cell-intrinsic Batf3-deficiency, but rather the lack of cDC1-mediated cross-priming. The gene discussed is CD8A; the disease is neoplasm.